Clinical Trials in Denver

Showing 14021-14040 of 15,604 trials

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

NCT00098059

This study will evaluate the safety and blood levels of a new pediatric formulation of Famvir in children 1-12 years of age. In Part A, patients will receive a single dose of famciclovir (12.5 mg/kg) to assess pharmacokinetics (PK) and safety. In Part B, patients will receive multiple doses of famciclovir alone or with concomitant oral anti-herpes therapy to assess safety and tolerability. Part B will start only after PK data from Part A had been analyzed.

Herpes Simplex

Novartis Pharmaceuticals74 participantsStarted Feb 2005

Birmingham, Alabama, United States • Denver, Colorado, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

NCT01338870

B2611003 is designed to study how safe and effective an investigational medication (PF-04991532) is in people with Type 2 diabetes. Subjects in the study will receive 1 of 6 treatments for 3 months. One of the treatments will be sitagliptin which is an approved drug, and another treatment will be placebo, which does not contain active ingredient.

Diabetes Mellitus, Type 2

Pfizer301 participantsStarted Jun 2011

Little Rock, Arkansas, United States • Roseville, California, United States • Denver, Colorado, United States +39 more locations

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Find Trials by Condition in Denver

Treatment of Moderate to Severe Facial Acne Vulgaris

S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Pilot Study of Minocycline in Huntington's Disease

Parent Perceptions of Weight Status: Impact of a Pilot Intervention

A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

Doxycycline and OA Progression

A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)

Advisa MRI Clinical Study

Drug Eluting Stent Registry of Thrombosis

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA)